Panbela Therapeutics, Inc.
PBLA
$0.2603
-$0.0607-18.91%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.66% | -42.23% | 25.04% | 27.68% | 30.27% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -95.33% | -140.39% | -96.97% | -96.54% | -95.39% |
| Change in Net Operating Assets | 371.74% | 369.16% | 157.27% | -215.74% | -304.98% |
| Cash from Operations | 42.69% | 8.86% | -21.15% | -65.29% | -117.36% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 93.75% | 117,600.00% | 160.61% | 160.61% | 160.61% |
| Cash from Investing | 93.75% | 117,600.00% | 160.98% | 160.98% | 133.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 39.39% | 39.39% | 39.39% | -- | -- |
| Issuance of Common Stock | -55.96% | -55.97% | -2.17% | 388.66% | 3,187.18% |
| Repurchase of Common Stock | 3.57% | -411.11% | -525.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 67.85% | 67.85% | 15.80% | -174.42% | -203.81% |
| Cash from Financing | -47.53% | -55.87% | 2.42% | 388.27% | 445,600.00% |
| Foreign Exchange rate Adjustments | 150.00% | -50.00% | 66.67% | 100.00% | -120.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,150.00% | -252.86% | -131.19% | 112.22% | 99.74% |